Quogue capitalizes Calistoga: Cancer play Calistoga adds $40M from VCs on top of $30M in 2009

Quogue capitalizes Calistoga

Wayne Rothbaum of Quogue Capital ventured out of his usual territory of biotech public market investment to lead last week's $40 million series C round for cancer and inflammatory disease company Calistoga Pharmaceuticals Inc.

New investor Latterell Venture

Read the full 392 word article

How to gain access

Continue reading with a
two-week free trial.